Clearside Biomedical, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 02/11/2025 | 2.81 M | $2.67 M | -1.18% | 3.75% |
CARMIGNAC GESTION | 02/13/2025 | 1.93 M | $1.84 M | 0.00% | 2.59% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 877,647 | $833,765 | 9.17% | 1.17% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 764,058 | $726,017 | 4.47% | 1.02% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 721,789 | $685,700 | -3.10% | 0.97% |
FIRST MANHATTAN CO. LLC. | 02/14/2025 | 405,668 | $385,385 | -39.10% | 0.54% |
STATE STREET CORP | 02/14/2025 | 265,263 | $252,000 | 29.29% | 0.35% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 255,000 | $242,250 | 0.00% | 0.34% |
UBS GROUP AG | 02/14/2025 | 145,118 | $137,862 | 100.00% | 0.19% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 131,913 | $125,317 | -48.69% | 0.18% |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 108,244 | $102,832 | 0.30% | 0.14% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 101,208 | $96,148 | 9.14% | 0.14% |
BROWN WEALTH MANAGEMENT, LLC | 02/14/2025 | 100,000 | $95,000 | 0.00% | 0.13% |
NORTHEAST FINANCIAL CONSULTANTS INC | 02/14/2025 | 93,000 | $88,350 | 0.00% | 0.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 59,038 | $56,086 | 190.56% | 0.08% |
02/14/2025 | 33,800 | $32,000 | 100.00% | 0.05% | |
NEWMAN DIGNAN & SHEERAR, INC. | 01/30/2025 | 30,123 | $28,617 | 7.49% | 0.04% |
SYNOVUS FINANCIAL CORP | 02/13/2025 | 30,000 | $28,500 | -43.47% | 0.04% |
02/12/2025 | 24,500 | $23,275 | 100.00% | 0.03% | |
STIFEL FINANCIAL CORP | 02/13/2025 | 23,944 | $22,747 | 4.36% | 0.03% |
WAVERLY ADVISORS, LLC | 02/14/2025 | 21,965 | $20,867 | 0.00% | 0.03% |
01/13/2025 | 21,500 | $20,425 | 100.00% | 0.03% | |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 21,196 | $20,136 | 100.00% | 0.03% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 20,216 | $19,205 | 0.00% | 0.03% |
PRUDENTIAL FINANCIAL INC | 02/11/2025 | 19,400 | $18,430 | -45.20% | 0.03% |
MARINER, LLC | 02/13/2025 | 18,950 | $18,003 | 0.00% | 0.03% |
OPPENHEIMER & CO INC | 02/05/2025 | 14,341 | $13,624 | 100.00% | 0.02% |
STRATOS WEALTH ADVISORS, LLC | 01/27/2025 | 14,000 | $13,300 | 0.00% | 0.02% |
VIRTU FINANCIAL LLC | 02/11/2025 | 13,505 | $13,000 | 100.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 12,100 | $11,495 | -60.46% | 0.02% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 10,500 | $10,000 | 0.00% | 0.01% |
JPMORGAN CHASE & CO | 02/12/2025 | 10,358 | $9,841 | -0.06% | 0.01% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 10,000 | $10,000 | 0.00% | 0.01% |
ROCKWOOD WEALTH MANAGEMENT, LLC | 01/21/2025 | 10,000 | $9,948 | 0.00% | 0.01% |
MALAGA COVE CAPITAL, LLC | 02/14/2025 | 10,000 | $9,500 | 100.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 6,011 | $5,710 | 98.38% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1,200 | $1,460 | 0.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 1,100 | $1,070 | 0.00% | 0.00% |
02/06/2025 | 380 | $361 | 100.00% | 0.00% | |
RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 145 | $138 | 0.00% | 0.00% |
CREATIVE FINANCIAL DESIGNS INC /ADV | 02/10/2025 | 100 | $95 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 2 | $2 | 0.00% | 0.00% |
JOHNSON & JOHNSON | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
WOLVERINE TRADING, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Clearside Biomedical, Inc. institutional Ownership - FAQ's
During the previous two years, 74 institutional investors and hedge funds held shares of Clearside Biomedical, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.81 M
Carmignac Gestion: 1.93 M
BlackRock Funding, Inc. /DE: 877,647
GEODE CAPITAL MANAGEMENT, LLC: 764,058
RENAISSANCE TECHNOLOGIES LLC: 721,789
FIRST MANHATTAN CO. LLC.: 405,668
12.63% of Clearside Biomedical, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.45 M shares in the last 24 months. This purchase volume represents approximately $13.31 M in transactions.